Keros Therapeutics Inc (KROS)
57.08
-0.64
(-1.11%)
USD |
NASDAQ |
May 02, 16:00
57.13
+0.05
(+0.09%)
Pre-Market: 20:00
Keros Therapeutics Revenue (TTM)
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2019 | 10.00M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
10.00M
Minimum
Dec 2019
10.00M
Maximum
Dec 2019
10.00M
Average
10.00M
Median
Dec 2019
Revenue (TTM) Benchmarks
Regeneron Pharmaceuticals Inc | 13.12B |
Scholar Rock Holding Corp | -- |
Morphic Holding Inc | -- |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |